Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-11-16 | 2023-11-23 | 210431 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-12-07 | 2024-03-21 | 212730 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Actual shortage | 2024-05-16 | 2024-05-16 | 228149 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2017-08-21 | 2017-09-19 | 19937 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-25 | 131063 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-08 | 2023-07-05 | 194054 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-19 | 2023-10-03 | 195518 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-03-26 | 95411 |
| NOVAMOXIN | 50MG | GRANULES FOR SUSPENSION | Resolved | 2020-02-07 | 2020-06-11 | 105596 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-05-14 | 2020-06-04 | 115196 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-05-19 | 2022-07-01 | 160983 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-18 | 2022-09-08 | 167159 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-09-22 | 2024-02-14 | 169966 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172263 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-02-02 | 2023-07-05 | 183361 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-11-03 | 195109 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195112 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195207 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |